Targeting lactate with a GLUT1 inhibitor reverses PARP inhibitor resistance in ovarian cancer
Acta Biochimica et Biophysica Sinica · 01.11.2026 · 58 (11) · 2417-2430
DOI: 10.3724/abbs.2025249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 26.05.2026. Verfasst von Shuqi Nie und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Ovarian Neoplasms, Drug Resistance, Neoplasm, Glucose Transporter Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Nie, S., Pu, C., Liu, H., Pei, X., Wang, Y., Lu, X., Cheng, Y., Jiang, W., & Yang, H. (2026). Targeting lactate with a GLUT1 inhibitor reverses PARP inhibitor resistance in ovarian cancer. Acta Biochimica et Biophysica Sinica, 58(11), 2417-2430. https://doi.org/10.3724/abbs.2025249
Vancouver
Nie S, Pu C, Liu H, Pei X, Wang Y, Lu X, et al. Targeting lactate with a GLUT1 inhibitor reverses PARP inhibitor resistance in ovarian cancer. Acta Biochimica et Biophysica Sinica. 2026;58(11):2417-2430. doi:10.3724/abbs.2025249
BibTeX
@article{Nie2026,
author = {Nie, Shuqi and Pu, Congli and Liu, Hongyu and Pei, Xuan and Wang, Yi and Lu, Xiaohang and Cheng, Yufan and Jiang, Wei and Yang, Huijuan},
title = {Targeting lactate with a GLUT1 inhibitor reverses PARP inhibitor resistance in ovarian cancer},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
volume = {58},
number = {11},
pages = {2417--2430},
doi = {10.3724/abbs.2025249}
}
EUVIMED